miR-133a suppresses ovarian cancer cell proliferation by directly targeting insulin-like growth factor 1 receptor

Area of Science:

• Molecular Biology
• Oncology
• Genetics

Background:

• MicroRNA miR-133a is frequently dysregulated in various cancers.
• The specific role and regulatory mechanisms of miR-133a in ovarian cancer are not well understood.

Purpose of the Study:

• To investigate the function of miR-133a in ovarian cancer.
• To identify the molecular targets of miR-133a in ovarian cancer cells.

Main Methods:

• Quantitative real-time PCR to measure miR-133a expression levels.
• Cell proliferation, colony formation, and cell cycle assays to assess miR-133a function.
• In vivo tumor xenograft models in nude mice.
• Luciferase reporter assays to validate miR-133a binding to IGF1R 3'-UTR.
• Western blot and qRT-PCR to measure IGF1R expression.

Main Results:

• miR-133a expression was significantly reduced in ovarian cancer tissues.
• Overexpression of miR-133a inhibited ovarian cancer cell proliferation, colony formation, and induced G1 cell cycle arrest.
• miR-133a overexpression suppressed tumor growth in vivo.
• miR-133a directly targets the 3'-UTR of insulin-like growth factor 1 receptor (IGF1R).
• miR-133a overexpression reduced IGF1R mRNA and protein levels.
• IGF1R re-expression rescued the suppressive effects of miR-133a on ovarian cancer cell proliferation.

Conclusions:

• miR-133a acts as a tumor suppressor in ovarian cancer.
• The tumor-suppressive function of miR-133a is mediated through the direct inhibition of IGF1R expression.
• miR-133a represents a potential therapeutic target for ovarian cancer.